Characteristics, risk management and GMP standards of pharmaceutical companies in China
| dc.contributor.author | Chen, Hong | |
| dc.contributor.author | Qin, Lijian | |
| dc.contributor.author | Jiang, Cong | |
| dc.contributor.author | Qin, Mingshuai | |
| dc.contributor.author | Sun, Yanming | |
| dc.contributor.author | Luo, Jingjing | |
| dc.date.accessioned | 2023-12-19T08:55:57Z | |
| dc.date.available | 2023-12-19T08:55:57Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | The Good Manufacturing Practice (GMP) is one of the gold standards by which governments worldwide judge modern pharmaceutical companies’ production processes and product-safety standards. However, in all the nations, it is di cult to obtain real data about GMP inspection results, so conducting the related research is impossible. Taking advantage of a rare chance to obtain the on-site GMP inspection results in China, we have been able to initiate an empirical analysis of how company characteristics and risk management a | cs |
| dc.description.firstpage | art. no. 1103555 | cs |
| dc.description.source | Web of Science | cs |
| dc.description.volume | 11 | cs |
| dc.identifier.citation | Frontiers in Public Health. 2023, vol. 11, art. no. 1103555. | cs |
| dc.identifier.doi | 10.3389/fpubh.2023.1103555 | |
| dc.identifier.issn | 2296-2565 | |
| dc.identifier.uri | http://hdl.handle.net/10084/151847 | |
| dc.identifier.wos | 000954246800001 | |
| dc.language.iso | en | cs |
| dc.publisher | Frontiers Media S.A. | cs |
| dc.relation.ispartofseries | Frontiers in Public Health | cs |
| dc.relation.uri | https://doi.org/10.3389/fpubh.2023.1103555 | cs |
| dc.rights | © 2023 Chen, Qin, Jiang, Qin, Sun and Luo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | cs |
| dc.rights.access | openAccess | cs |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | cs |
| dc.subject | pharmaceutical company characteristics | cs |
| dc.subject | risk management | cs |
| dc.subject | GMP | cs |
| dc.subject | pharmaceutical company supervision | cs |
| dc.subject | China | cs |
| dc.title | Characteristics, risk management and GMP standards of pharmaceutical companies in China | cs |
| dc.type | article | cs |
| dc.type.status | Peer-reviewed | cs |
| dc.type.version | publishedVersion | cs |
Files
Original bundle
1 - 1 out of 1 results
Loading...
- Name:
- 2296-2565-2023v11an1103555.pdf
- Size:
- 498.08 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 out of 1 results
Loading...
- Name:
- license.txt
- Size:
- 718 B
- Format:
- Item-specific license agreed upon to submission
- Description: